Page last updated: 2024-10-28

haloperidol and Barrett Epithelium

haloperidol has been researched along with Barrett Epithelium in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krakauer, EL1
Zhu, AX1
Bounds, BC1
Sahani, D1
McDonald, KR1
Brachtel, EF1

Other Studies

1 other study available for haloperidol and Barrett Epithelium

ArticleYear
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2005. A 58-year-old man with esophageal cancer and nausea, vomiting, and intractable hiccups.
    The New England journal of medicine, 2005, Feb-24, Volume: 352, Issue:8

    Topics: Adenocarcinoma; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents, Hormonal; Barrett Esop

2005